Invesco
HGEN

Invesco’s HUMANIGEN, INC. HGEN Stock Holding History

Invesco’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,032
Closed -$57K – 4193
2022
Q1 		$57K Sell
19,032
-146
-0.8% -$391 ﹤0.01% 3921
2021
Q4 		$71K Buy
19,178
+201
+1% +$1.18K ﹤0.01% 3943
2021
Q3 		$113K Buy
18,977
+4,024
+27% +$56.5K ﹤0.01% 3918
2021
Q2 		$260K Buy
+14,953
New +$273K ﹤0.01% 3689

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco's HGEN Position: Q2 2022 in Review

Invesco sold out of HUMANIGEN, INC. (HGEN) in Q2 2022, closing a stake of 19,032 shares — an estimated $57K sold.

Invesco first reported a position in HGEN in Q2 2021 and held it in 4 quarters. The position peaked at $260K in Q2 2021. 65 funds tracked by Wall St. Rank hold HGEN as of Q2 2022.

  • Invesco reported no remaining HUMANIGEN, INC. position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 19,032 HUMANIGEN, INC. shares in Q2 2022, an estimated $57K.
  • Invesco first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 4 quarters.
  • Invesco's HUMANIGEN, INC. position peaked at $260K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.